Literature DB >> 29261410

Cross Talk between Radiation and Immunotherapy: The Twain Shall Meet.

Swaminathan P Iyer1, Clayton R Hunt2, Tej K Pandita2.   

Abstract

There has been increased interest in the immune stimulatory properties of ionizing radiation based on several preclinical models and recently completed clinical studies performed in combination with checkpoint inhibitors. This is a paradigm shift in that it considers the role of radiation beyond its direct cytotoxic effects, however, the factors that promote or limit radiation-induced immunogenicity are still unclear. Here we review the role of radiation in modulating the various aspects of the tumor immune microenvironment and discuss in particular the direct effects of radiation on the DNA damage response and its immediate consequences to neighboring cells. The latter "danger response" in particular can enhance recruitment of dendritic and macrophage cells to the tumor microenvironment, which in turn can activate or diminish subsequent T-cell priming. Identification of the critical factors that modulate the interaction between radiation-induced cell damage and the immune system will allow for rational combinational therapy design and the development of biomarkers that predict effective immune responses.

Entities:  

Mesh:

Year:  2017        PMID: 29261410      PMCID: PMC5858718          DOI: 10.1667/RR14941.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  45 in total

Review 1.  Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

Authors:  Pramod Srivastava
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Protein degradation and the generation of MHC class I-presented peptides.

Authors:  Kenneth L Rock; Ian A York; Tomo Saric; Alfred L Goldberg
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

Review 3.  Spontaneous regression of cancer.

Authors:  R J Papac
Journal:  Cancer Treat Rev       Date:  1996-11       Impact factor: 12.111

4.  WTAP is a novel oncogenic protein in acute myeloid leukemia.

Authors:  H Bansal; Q Yihua; S P Iyer; S Ganapathy; D A Proia; D Proia; L O Penalva; P J Uren; U Suresh; J S Carew; A B Karnad; S Weitman; G E Tomlinson; M K Rao; S M Kornblau; S Bansal
Journal:  Leukemia       Date:  2014-01-13       Impact factor: 11.528

5.  Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.

Authors:  Rui Wang; Jie Zhang; Sufeng Chen; Meng Lu; Xiaoyang Luo; Shihua Yao; Shilei Liu; Ying Qin; Haiquan Chen
Journal:  Lung Cancer       Date:  2011-05-20       Impact factor: 5.705

6.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

7.  The abscopal effect associated with a systemic anti-melanoma immune response.

Authors:  Emily F Stamell; Jedd D Wolchok; Sacha Gnjatic; Nancy Y Lee; Isaac Brownell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-05       Impact factor: 7.038

8.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

9.  RAD51 interconnects between DNA replication, DNA repair and immunity.

Authors:  Souparno Bhattacharya; Kalayarasan Srinivasan; Salim Abdisalaam; Fengtao Su; Prithvi Raj; Igor Dozmorov; Ritu Mishra; Edward K Wakeland; Subroto Ghose; Shibani Mukherjee; Aroumougame Asaithamby
Journal:  Nucleic Acids Res       Date:  2017-05-05       Impact factor: 16.971

Review 10.  STING: infection, inflammation and cancer.

Authors:  Glen N Barber
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

View more
  3 in total

Review 1.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

2.  Definitive Radiotherapy With SBRT or IMRT Boost for Breast Cancer: Excellent Local Control and Cosmetic Outcome.

Authors:  Yuta Shibamoto; Taro Murai; Kazushi Suzuki; Chisa Hashizume; Kengo Ohta; Yuki Yamada; Masanari Niwa; Akira Torii; Masashi Shimohira
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

Review 3.  Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance.

Authors:  Varintra E Krisnawan; Jennifer A Stanley; Julie K Schwarz; David G DeNardo
Journal:  Cancers (Basel)       Date:  2020-10-11       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.